跳到正文

面向境外患者的中国就医独立信息

菜单

疾病

乳腺癌Breast cancer

乳腺癌 · ICD-10：C50 — Malignant neoplasm of breast

分组： 肿瘤 专科： 乳腺外科

关键数据

仅为已发布的数值。每个图块都会打开带有其来源、年份与口径的章节。

疾病详情

规范中文名
乳腺癌
英文名
Malignant neoplasm of breast

以中文写出的数值按来源原样引用。

又称

  • 乳癌
  • 乳腺肿瘤
  • 乳腺恶性肿瘤
  • Breast cancer
  • BC

治疗费用区间

以下每个区间都按一种计费口径发布：医保报销前。 来源未发布报销后数值，因此这里不展示。

治疗路径 费用区间 价格依据 数据年份
手术 18000 – 28430 CNY 病种打包全包价 2020–2025
放疗 27000 – 45000 CNY 项目价 2025–2026
化疗 6200 – 9000 CNY 病种打包全包价 2020–2021
靶向 100000 – 195000 CNY 项目价 2025
免疫 32043 – 42620 CNY 项目价 2024–2025

上方的条形共用同一刻度：每条从该行已发布的下限值起，到其上限值止。本页最高的上限值为 195000 CNY。每行保留自己的数据年份与口径。

该疾病的 5 个费用区间，来源见各行页面。

以中文写出的数值按来源原样引用。

查看全部费用区间 →

五年生存

5 年生存率 80.9% 95% 置信区间 80.5–81.3

人群
总体（全分期合并）· 年龄标准化相对生存率
时期
2019–2021
发布机构
国家癌症中心
数值性质
估计值（混合法）
登记范围
281 个肿瘤登记处
分期数据可用性
未发布

以中文写出的数值按来源原样引用。

查看全部生存率 →

如何解读该数据。 它按全分期合并发布，因此是全国登记数据中所有人的平均值，而不是对某个人的预后。对多数癌症而言，确诊时的分期是生存差异背后最强的单一因素：通常，癌症发现得越早，生存率越高；发现得越晚，越低。不同癌症之间的比较也受到各自通常确诊早晚的影响，因此一个较低的数值本身并不意味着诊疗更差。

该数值是相对生存率：它把被诊断患此癌的人与一般人群中同年龄、同性别的人相比较，且为年龄标准化，因此它不是五年后仍存活患者所占的比例。它以估计值（混合分析）发布，因为登记报告存在滞后，故国家癌症中心对最近一段时期作了模型估计。作为参照，同一来源发布 2019–2021 年全部癌症合计的五年相对生存率为 43.7%。

在该疾病上有已发布记录的医院

依据官方公开数据来源筛选

这些医院依据官方公开数据来源筛选——复旦大学医院专科声誉排行榜、国家临床重点专科名单与国家临床医学研究中心——因此卡片上的每一行都可与其已发布的来源核对。这不是付费或推广位。

这些医院是如何筛选的

入选。当某疾病所归属的专科满足以下至少一项时，医院即被列入该疾病：在复旦大学医院专科声誉排行榜中有一个名次或提名；有一条 A、B 或 C 级的国家临床重点专科记录；或该专科有一个国家临床医学研究中心或国家重点实验室。JCI 认证仅作徽标展示；它绝不决定入选，也绝不决定排序。

排序。第 1 步：该专科在复旦榜中的第 1 至第 10 名。第 2 步：又一个复旦名次，或一个提名。第 3 步：一条 A 级国家临床重点专科。第 4 步：一条 B 级国家临床重点专科。第 5 步：该专科的一个国家临床医学研究中心或国家重点实验室，研究中心优先于实验室。第 6 步：一条 C 级国家临床重点专科——这是我们发布的一条没有独立官方来源的记录，因此排在其余之后。

平局。在同一步骤内：复旦名次更好的在前，其次重点专科等级更高者（A 先于 B，B 先于 C），再次省份，再次城市，最后医院名称——与医院目录所用的省—市—名称顺序相同。最多列出八家医院。

当名单较短时。五家及以上：列出前八家。三家或四家：全部列出，并有一个可展开的折叠区，把其余记录补至最多八条，每条都带其证据等级。一两家：同上，且该折叠区默认展开，并有一行说明有多少家医院有可靠的公开记录。没有：页面说明未找到可靠的公开记录，并链接到专科目录。绝不为了凑数而编造名次、机构或数量。

复旦排行榜是中国临床医生最广泛认可的医院专科声誉排行榜，由复旦大学医院管理研究所每年发布。

  1. 四川大学华西医院West China Hospital, Sichuan University

    Chengdu 成都市

    国家临床重点专科

    同时上榜：在复旦榜中为 General Surgery #3, Thoracic Surgery #4, Urology #2 （并列）。

  2. 山东大学齐鲁医院Qilu Hospital of Shandong University

    Jinan 济南市

    国家临床重点专科

    已发表研究

    另有 3 项已发表研究

    PubMed 收录了 5 篇关于该疾病、并提及这家医院的论文。

    同时上榜：在复旦榜中为 Gynecology #7 （并列）, Otorhinolaryngology 获提名, Gastroenterology 获提名。

  3. 山东省肿瘤医院Shandong Cancer Hospital

    Jinan 济南市

    国家临床重点专科

  4. 湖北省肿瘤医院Hubei Cancer Hospital

    Wuhan 武汉市

    国家临床重点专科

    已发表研究

    另有 3 项已发表研究

    PubMed 收录了 5 篇关于该疾病、并提及这家医院的论文。

  5. 湖南省肿瘤医院Hunan Cancer Hospital

    Changsha 长沙市

    国家临床重点专科

    已发表研究

    PubMed 收录了 1 篇关于该疾病、并提及这家医院的论文。

    同时上榜：在复旦榜中为 Medical Oncology 获提名。

临床试验（在研治疗）

除标准治疗外，针对 Breast cancer 的临床研究目前可能在中国开放招募受试者。在研治疗尚未获监管机构批准为标准疗法——它们是临床研究，而非常规治疗。每条记录都注明主要研究者与开展研究的医院。如有兴趣，请联系医院了解是否符合条件，并自行决定是否申请。

  1. 研究 To Evaluate the Efficacy and Safety of Ipsilateral Supraclavicular Lymph Node Dissection for Breast Cancer Patients: A Prospective, Multicenter, Non-interventionist Real World Study

    医院
    Henan Cancer Hospital
    状态
    招募中
    登记库
    NCT06605521

  2. 研究 Integrated PET/MRI Study of Cognitive Impairment in Premenopausal Breast Cancer Patients After Chemotherapy or Endocrine Therapy

    状态
    招募中
    登记库
    NCT05305092

  3. 研究 The Impact of Socioeconomic Determinants on the Patient Reported Outcomes in Young Breast Cancer Patients After Breast Surgery: an Observational Cohort Study

    主要研究者
    Chen Kai · Clinical Professor
    医院
    Sun Yat-sen Memorial Hospital, Sun Yat-sen University
    状态
    招募中
    登记库
    NCT06425874

  4. 研究 Neoadjuvant Therapy for Early Triple-Negative Breast Cancer: A Response-Guided Approach Using Iparomlimab and Tuvonralimab Injection in Combination With Chemotherapy

    医院
    Tianjin Medical University Cancer Institute & Hospital
    状态
    招募中
    登记库
    NCT07372079

  5. 研究 Clinical Study of 18F-Labeled FAPI-04 in PET Imaging of Breast Cancer

    医院
    The Affiliated Hospital of Qingdao University
    状态
    招募中
    登记库
    NCT06916338
另有 126 项已登记研究

  1. 研究 Efficacy and Safety of Pyrotinib Maleate Combined With ARX788 Neoadjuvant Treatment in Stage II-III HER2-positive Breast Cancer Patients Who Have Poor Outcomes After Treatment With Trastuzumab and Pertuzumab

    主要研究者
    Caigang Liu · Director
    医院
    Shengjing Hospital
    状态
    招募中
    登记库
    NCT04983121

  2. 研究 Effect of Circulating Tumor Cell Detection in Patients With Luminal A Breast Cancer Without Lymph Node Metastasis Instead of Conventional Imaging Examination After Operation: a Non-Inferiority Randomized Controlled Clinical Trial

    主要研究者
    Jianyi Li · Principal Investigator
    医院
    Shengjing Hospital
    状态
    招募中
    登记库
    NCT04065321

  3. 研究 A Phase II Study of SHR-A1811 Monotherapy or Combined With Pyrotinib Maleate as Neoadjuvant Treatment in HER2-positive Breast Cancer Patients

    主要研究者
    Caigang Liu · Director of the Cancer Center
    医院
    Shengjing Hospital
    状态
    招募中
    登记库
    NCT05635487

  4. 研究 VERITAS Longitudinal Real-world Registry of HR+/HER2- mBC to Understand Treatment Pattern and Clinical Outcomes in HR+/HER2- mBC

    医院
    Jiangsu Province Hospital
    状态
    招募中
    登记库
    NCT07743944

  5. 研究 A Phase II Study of SPH4336 in Combination With Endocrine Therapy in HR-positive, HER2-negative Breast Cancer Patients With Brain Metastases.

    医院
    Anhui Provincial Hospital
    状态
    招募中
    登记库
    NCT05872347

  6. 研究 Application of CT-Linac-Based "All-in-One" One-Stop Radiotherapy in All-Scenario Breast Cancer Radiotherapy: A Prospective Clinical Study

    主要研究者
    Xiaoli Yu · Professor
    医院
    Fudan University Shanghai Cancer Center
    状态
    招募中
    登记库
    NCT07776301

  7. 研究 A Cohort Study of Adjuvant Therapy With Taxane Combined Targeted Therapy for Low-risk HER2 Positive and Lymph Node Negative Breast Cancer

    主要研究者
    Shu Wang · director of breast center
    医院
    Peking University People's Hospital
    状态
    招募中
    登记库
    NCT06711055

  8. 研究 Neoadjuvant Therapy Study Guided by Drug Screening in Vitro Patient-derived Tumor-like Cell Clusters for HER2 Positive Early Breast Cancer Patients

    医院
    Peking University People's Hospital
    状态
    招募中
    登记库
    NCT04750122

  9. 研究 Clinical Efficacy and Safety Assessment of Breast-Conserving Surgery for Central Breast Cancer: A Prospective Randomized Controlled Trial

    状态
    招募中
    登记库
    NCT06938360

  10. 研究 A Single-arm, Prospective Phase II Study of Camrelizumab Plus Apatinib and Chemotherapy as Neoadjuvant Therapy for Triple Negative Breast Cancer (TNBC)

    主要研究者
    Shuangyue Liu · Clinical Professor
    医院
    West China Hospital, Sichuan University
    状态
    招募中
    登记库
    NCT05447702

  11. 研究 Application of Radiomics in Correlation Between Ultrasound Characteristics and Pathological Prognostic Factors in Breast Cancer

    医院
    The Second Affiliated Hospital Zhejiang University School of Medicine
    状态
    招募中
    登记库
    NCT04483804

  12. 研究 Pilot Study on the Clinical Efficacy of Focused Ultrasound-Mediated Targeted Drug Delivery System Combined With Neoadjuvant Therapy for HER2-Positive Breast Cancer

    医院
    The Second Affiliated Hospital Zhejiang University School of Medicine
    状态
    招募中
    登记库
    NCT07616440

  13. 研究 Neoadjuvant Chemotherapy Plus Pyrotinib and Trastuzumab for HER2-positive Breast Cancer (NEOTORCH-BREAST05): A Prospective, Single-arm, Multi-center Clinical Study

    医院
    The First Affiliated Hospital, Zhejiang University School of Medicine
    状态
    招募中
    登记库
    NCT06832904

  14. 研究 Safety and Feasibility of Irreversible Electroporation for Early-stage Breast Cancer: a Prospective, Open-Label, Single-Arm, Exploratory Study

    主要研究者
    Tian'an Jiang · Chief Physician
    医院
    The First Affiliated Hospital, Zhejiang University School of Medicine
    状态
    招募中
    登记库
    NCT07263451

  15. 研究 Digital Cognitive Behavioral Therapy for Insomnia (dCBT-I) for Chronic Insomnia in Breast Cancer Survivors, A Randomized Controlled Trial

    主要研究者
    Jing MA · Pro.
    医院
    Peking University First Hospital
    状态
    招募中
    登记库
    NCT05813392

  16. 研究 Impact of Erector Spinae Plane Block With Adjuvant Dexmedetomidine on Chronic Postsurgical Pain in Breast Cancer Patients: a Two-center Randomized Controlled Trial

    主要研究者
    Dong-Xin Wang · Professor
    医院
    Peking University First Hospital
    状态
    招募中
    登记库
    NCT05494502

  17. 研究 A Randomized, Double-Blind, Placebo-Controlled Phase III Trial of GB491 in Combination With Letrozole in Subjects With HR Positive and HER2 Negative Locally Advanced or Metastatic Breast Cancer Who Have Not Previously Received Systemic Therapy in This Disease Setting

    医院
    First Affiliated Hospital of Guangzhou Medical University
    状态
    招募中
    登记库
    NCT05851014

  18. 研究 A Phase III, Multicenter, Open-label, Randomized Controlled Study Comparing GQ1005 and Trastuzumab Emtansine (T-DM1) in Patients With HER2-Positive Unresectable or Metastatic Breast Cancer Previously Treated With Trastuzumab and a Taxane

    医院
    First Affiliated Hospital of Guangzhou Medical University
    状态
    招募中
    登记库
    NCT07673029

  19. 研究 A Real-World Observational Study on Post-Resistance Treatment Outcomes in Advanced Breast Cancer Patients After CDK4/6 Inhibitors, PIK3CA Inhibitors, or Trastuzumab Deruxtecan Therapy

    医院
    Hunan Cancer Hospital
    状态
    招募中
    登记库
    NCT07073755

  20. 研究 A New Option for Post-CDK4/6is Resistance Era: Multicenter Real-world Study of Anlotinib-based Combination Therapy in Hormone Receptor-positive Metastatic Breast Cancer Resistant to CDK4/6is.

    医院
    Hunan Cancer Hospital
    状态
    招募中
    登记库
    NCT06734533

  21. 研究 A Prospective, Multigroup, Multi-center, Open-label Clinical Study of Trastuzumab Rezetecan as Neoadjuvant Therapy Combined With Toripalimab in HR+/HER2-low Breast Cancer Patients (NEOTORCH-BREAST 08)

    医院
    Third Affiliated Hospital of Harbin Medical University
    状态
    招募中
    登记库
    NCT07383818

  22. 研究 A Randomized, Multi-center, Open-label, Phase III Trial of Fulvestrant Versus Capecitabine as Maintenance Therapy After First-line Chemotherapy in Patients With Hormone Receptor Positive, Human Epidermal Growth Factor Receptor-2 Negative Metastatic Breast Cancer (FAMILY)

    主要研究者
    Herui Yao · Principal Investigator
    医院
    Guangdong Provincial People's Hospital
    状态
    招募中
    登记库
    NCT04263298

  23. 研究 A Randomized, Open-label, Multicenter Study Comparing Continuation of Original Targeted Therapy With Trastuzumab Combined With Pyrotinib and Capecitabine as Postoperative Adjuvant Therapy in Non-pCR Patients With HER2 Positive Early Breast Cancer

    医院
    Fujian Medical University Union Hospital
    状态
    招募中
    登记库
    NCT05292742

  24. 研究 Trastuzumab Combined With Pyrotinib and Chemotherapy for Locally Advanced, Inflammatory, or Early HER2-positive Mammary glandsCancer: One Arm, Open, Phase II Clinical Study

    主要研究者
    Tao OUYANG · Chairman of Breast Center of Peking University Cancer Hospital
    医院
    Peking University Cancer Hospital
    状态
    招募中
    登记库
    NCT04481932

  25. 研究 Intraoperative Nomogram to Predict Breast Cancer- Related Lymphedema Based in Artificial Intelligence Image Recognition: a Randomized Controlled Trial

    主要研究者
    Gaosong Wu, Ph D, MD · Director
    医院
    Zhongnan Hospital of Wuhan University
    状态
    招募中
    登记库
    NCT04665882

  26. 研究 A Phase 1a/1b Study Investigating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Antitumor Activity of the CDK4 Inhibitor BGB-43395, Alone or as Part of Combination Therapies in Patients With Metastatic HR+/HER2- Breast Cancer and Other Advanced Solid Tumors

    医院
    Peking University Cancer Hospital
    状态
    招募中
    登记库
    NCT06120283

  27. 研究 A Randomized Controlled, Open-label, Multicenter Clinical Study of Pyrotinib Maleate Combined With Trastuzumab,Dalpiciclib, and Letrozole Versus Trastuzumab Combined With Pertuzumab, Docetaxel, and Carboplatin as Neoadjuvant Therapy for Stage II-III HR +/HER2 + Breast Cancer

    主要研究者
    Caigang Liu · Professor
    医院
    Shengjing Hospital
    状态
    招募中
    登记库
    NCT05638594

  28. 研究 Evaluation of Axillary Lymph Nodes Using Prone Positioning Computed Tomography Scan and Ultrasound in Patients With Breast Cancer

    主要研究者
    Jianyi Li · Principal Investigator
    医院
    Shengjing Hospital
    状态
    招募中
    登记库
    NCT05346510

  29. 研究 A Phase II, Multicenter, Open-Label Neoadjuvant Study to Evaluate the Safety and Efficacy of Disitamab Vedotin in Combination With Pertuzumab With or Without Toripalimab for HER2 Positive Breast Cancer

    医院
    Fudan University Shanghai Cancer Center
    状态
    招募中
    登记库
    NCT06178159

  30. 研究 Effect of Neoadjuvant Radiation and Prediction of Response to Treatment in Locally Advanced Breast Cancer

    主要研究者
    Xiaoli Yu · Professor
    医院
    Fudan University Shanghai Cancer Center
    状态
    招募中
    登记库
    NCT05479409

  31. 研究 A Cohort Study of Different Choice of Adjuvant Therapy in Non-PCR Patients With HER2 Positive Early Breast Cancer After Neoadjuvant Therapy

    主要研究者
    Shu Wang · director of breast center
    医院
    Peking University People's Hospital
    状态
    招募中
    登记库
    NCT06693037

  32. 研究 A Single-center, Single-arm, Open Study on the Treatment of Early Small Breast Cancer With Ultrasound-guided Vacuum-assisted Excision Combined With Surgery

    状态
    招募中
    登记库
    NCT07071402

  33. 研究 Research on the Potential Mechanisms Underlying the Efficacy Differences in Specific Neoadjuvant Treatment Regimens for Different Subtypes of Breast Cancer

    状态
    招募中
    登记库
    NCT07012720

  34. 研究 A Phase 3b, Multicenter, Global, Interventional, Open-label Study of Trastuzumab Deruxtecan (T-DXd), an Anti-HER2-Antibody Drug Conjugate (ADC), in Subjects Who Have Unresectable and/or Metastatic HER2-low or HER2 Immunohistochemistry (IHC) 0 Breast Cancer (DESTINY-Breast15)

    医院
    Beijing Hospital
    状态
    招募中
    登记库
    NCT05950945

  35. 研究 Development and Application of Accurate Detection Technology Based on Multimodal Data of Breast Cancer Comobid Depression

    医院
    Xiangya Hospital of Central South University
    状态
    招募中
    登记库
    NCT06938373

  36. 研究 A Multicenter, Phase III, Randomized Controlled Trial Comparing Camrelizumab Plus Apatinib and Eribulin Versus Physician's Choice Chemotherapy in the Treatment of Advanced Triple-Negative Breast Cancer

    主要研究者
    Jieqiong Liu, M.D., Ph.D. · Professor
    医院
    Sun Yat-sen Memorial Hospital, Sun Yat-sen University
    状态
    招募中
    登记库
    NCT06889688

  37. 研究 Fovinaciclib Plus Aromatase Inhibitors and Dual HER2 Blockade in a Response-Adapted Neoadjuvant Strategy for HR-Positive/HER2-Positive Early Breast Cancer (TAYLOR-003)

    医院
    First Affiliated Hospital of Guangzhou Medical University
    状态
    招募中
    登记库
    NCT07616427

  38. 研究 A Randomized, Open-label, Parallel-controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of TQB2102 for Injection Versus Trastuzumab Emtansine for Injection in Patients With HER2-positive Advanced Breast Cancer

    医院
    The First Affiliated Hospital of Anhui Medical University
    状态
    招募中
    登记库
    NCT07008976

  39. 研究 Monitoring Circulating Tumor DNA in Patients With Early Stage Breast Cancer

    状态
    招募中
    登记库
    NCT04353557

  40. 研究 A Prospective, Randomized Controlled Phase II Trial Investigating the Optimal Timing of Antibody Drug Conjugates in Advanced HER2-Negative Breast Cancer Patients

    主要研究者
    Tao Sun · Principal Investigator
    医院
    Liaoning Cancer Hospital
    状态
    招募中
    登记库
    NCT07657130

  41. 研究 A Single-arm, Open, Phase II Clinical Study of SBRT, Chemotherapy, and Ivonescimab Neoadjuvant Therapy for Luminal-type Breast Cancer

    主要研究者
    HAN GUANG · professor
    医院
    Hubei Cancer Hospital
    状态
    招募中
    登记库
    NCT06402435

  42. 研究 A Single-arm, Open, Phase II Clinical Study of SBRT, Chemotherapy, and Cadonilimab (AK104) Neoadjuvant Therapy for Triple-negative Breast Cancer (TNBC)

    主要研究者
    HAN GUANG · professor
    医院
    Hubei Cancer Hospital
    状态
    招募中
    登记库
    NCT06401005

  43. 研究 Gut Microbiota Changes in Breast Cancer Patients Treated With Pyrotinib and Correlation With Drug-Induced Diarrhea: An Observational Cohort Study

    主要研究者
    Xinhong Wu, PhD · vice-president
    医院
    Hubei Cancer Hospital
    状态
    招募中
    登记库
    NCT07264985

  44. 研究 Large Segmentation Radiotherapy±Deep Inspiratory Breath Hold for Left Sided Breast Cancer, A Real-World Study

    医院
    Peking Union Medical College Hospital
    状态
    招募中
    登记库
    NCT06660628

  45. 研究 Application of 68GA-labeled CD73 Targeting Probe PET/CT Imaging in the Diagnosis of Breast Cancer

    医院
    Peking Union Medical College Hospital
    状态
    招募中
    登记库
    NCT06411678

  46. 研究 A Single-center, Blinded, Efficacious, Phase III Randomized Clinical Trial Initiated by Investigators to Investigate the Use of Surface Guided Radiation Therapy (SGRT) in Combination With Deep Inspiration Breath Hold (DIBH) Technique for Left Breast Cancer Treatment, Compared to Traditional Laser Alignment With Free Breathing Treatment

    医院
    Peking Union Medical College Hospital
    状态
    招募中
    登记库
    NCT05804916

  47. 研究 Effect of Huaier Granule on Postoperative Adjuvant Treatment for High-risk Early-stage Triple-negative Invasive Ductal Carcinoma: a Prospective, Multicenter, Randomized, Controlled, Open-label Study

    主要研究者
    Zhimin Shao · Professor
    医院
    The First Affiliated Hospital of Anhui Medical University
    状态
    招募中
    登记库
    NCT04790305

  48. 研究 Surveillance of Circulating Tumor Cell Phenotype in Early Stage Breast Cancer Patients With Neoadjuvant Chemotherapy or Adjuvant Chemotherapy

    医院
    Hunan Cancer Hospital
    状态
    招募中
    登记库
    NCT05326295

  49. 研究 A Single-arm, Multicenter, Open-labeled Clinical Study of UTD1 Combined With Capecitabine in Metastatic HER2-negative Breast Cancer Patients With Brain Metastases

    医院
    Hunan Cancer Hospital
    状态
    招募中
    登记库
    NCT05535413

  50. 研究 A Clinical Study of Darsilide Combined With AI, Trastuzumab and Patuzumab in the Neoadjuvant Treatment of HR Positive HER2 Positive Breast Cancer

    医院
    Henan Cancer Hospital
    状态
    招募中
    登记库
    NCT06276868

  51. 研究 Axillary Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Patients With Initial cN1 Breast Cancer: a Prospective, Multicenter, Single Arm, Real World Study

    医院
    Henan Cancer Hospital
    状态
    招募中
    登记库
    NCT06518135

  52. 研究 A Single-arm, Prospective, Open-label Phase II Clinical Study of Utidelone Combined With Bevacizumab in the Treatment of ≥ 2 Lines of HER-2 Negative Advanced Breast Cancer

    医院
    Henan Cancer Hospital
    状态
    招募中
    登记库
    NCT05398861

  53. 研究 Serplulimab Combined With Chemotherapy for Early-stage HR+/HER2- Breast Cancer

    主要研究者
    Zhenzhen Liu · Professor
    医院
    Henan Cancer Hospital
    状态
    招募中
    登记库
    NCT06860529

  54. 研究 Real-World Patient Characteristics, Treatment Patterns, and Outcomes for Patients With HER2 Negative Metastatic Breast Cancer Treated With Sacituzumab Govitecan: A Retrospective Trial in China（SACIT-OUT）

    主要研究者
    Wang Xiaojia · MD
    医院
    Zhejiang Cancer Hospital
    状态
    招募中
    登记库
    NCT06784921

  55. 研究 A Phase II, Randomised, Open-label, Multicentre Study of Posaconazole Plus PD-1 Inhibitors and Chemotherapy Versus PD-1 Inhibitors and Chemotherapy as Neoadjuvant Therapy for Triple Negative Breast Cancer

    主要研究者
    Yongsheng Wang · Professor
    医院
    Shandong Cancer Hospital
    状态
    招募中
    登记库
    NCT06802757

  56. 研究 Neoadjuvant Chemotherapy in Combination With Toripalimab for HR+/HER2- Breast Cancer : a Randomized, Open-label, Parallel-controlled, Multi-center Phase III Study (NEOTORCH-BREAST04)

    医院
    Sir Run Run Shaw Hospital Affiliated with Zhejiang University School of Medicine
    状态
    招募中
    登记库
    NCT06977893

  57. 研究 A Multi-center Prospective Observational Study to Assess the Effectiveness and Safety of Trastuzumab Deruxtecan in Chinese Breast Cancer Patients (REFRESH)

    医院
    China-Japan Friendship Hospital
    状态
    招募中
    登记库
    NCT06210776

  58. 研究 Pirfenidone Versus Placebo as Prophylaxis Against Acute Radiation-induced Lung Injury Following Hypofractionated Radiotherapy in Breast Cancer Patients (PRILI): A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study Evaluating

    主要研究者
    Yong Yang · Chief physician
    医院
    Fujian Medical University Union Hospital
    状态
    招募中
    登记库
    NCT05704166

  59. 研究 Internal Mammary Lymph Nodes Irradiation in High-risk Breast Cancer After Neoadjuvant Chemotherapy: a Phase III Randomized, Controlled Clinical Trial

    主要研究者
    Yong Yang · M.D.
    医院
    Fujian Medical University Union Hospital
    状态
    招募中
    登记库
    NCT06559696

  60. 研究 A Randomized, Open-label, Parallel-controlled, Multicenter Phase III Clinical Study Evaluating TQB2930 Combined With Investigator's Choice of Chemotherapy Versus Trastuzumab Combined With Investigator's Choice of Chemotherapy in the Treatment of HER2-Positive Advanced Breast Cancer

    医院
    First Affiliated Hospital of Guangzhou Medical University
    状态
    招募中
    登记库
    NCT07047365

  61. 研究 Efficacy and Safety of Probiotics Versus Standard Care in Preventing Diarrhea Induced by Neratinib in Breast Cancer Patients: A Prospective Randomized Controlled Clinical Trial

    医院
    Sun Yat-sen Memorial Hospital, Sun Yat-sen University
    状态
    招募中
    登记库
    NCT06892093

  62. 研究 Disitamab Vedotin in Combination With Pyrotinib Versus THP in the First-line Treatment for HER2-positive Advanced Breast Cancer, a Multicentre, Randomized, Double-blind Controlled, Phase III Trial

    医院
    Sun Yat-sen Memorial Hospital, Sun Yat-sen University
    状态
    招募中
    登记库
    NCT06278870

  63. 研究 Clinical Study on the Application of 18F-HER2 Affibody PET Imaging in HER2-Expressing Breast Cancer

    医院
    The Affiliated Hospital of Qingdao University
    状态
    招募中
    登记库
    NCT06916637

  64. 研究 A Non-interventional Study to Evaluate the Effectiveness and Safety of Inavolisib in Patients With Endocrine-resistant, PIK3CA-mutated, Hormone Receptor-positive, HER2-negative Locally Advanced or Metastatic Breast Cancer (reaINAVO)

    医院
    First Affiliated Hospital of Guangzhou Medical University
    状态
    招募中
    登记库
    NCT07347600

  65. 研究 An Interventional, Multicenter Study of Trastuzumab Rezetecan as Neoadjuvant Therapy in Patients With THP-Insensitive HER2-Positive Early Breast Cancer

    主要研究者
    Hao Zhou · Associate Chief Physician
    医院
    First Affiliated Hospital of Guangzhou Medical University
    状态
    招募中
    登记库
    NCT07647263

  66. 研究 Treatment of Triple-negative Breast Cancer With Albumin-bound Paclitaxel as Neoadjuvant Therapy: a Prospective Randomized Controlled Clinical Trial

    主要研究者
    Caigang Liu · Principal Investigator
    医院
    Shengjing Hospital
    状态
    招募中
    登记库
    NCT04137653

  67. 研究 The Association of Psychological Stress with the Efficacy of Neoadjuvant Therapy in Breast Cancer

    主要研究者
    Caigang Liu · Director of oncology
    医院
    Shengjing Hospital
    状态
    招募中
    登记库
    NCT06690645

  68. 研究 The Efficiency for Patient With Stage II-III HR+/HER2+ Early Breast Cancer With Standard Neoadjuvant Therapy: a Retrospective, Multicenter Study in Real World Settings.

    主要研究者
    Caigang Liu · Professor
    医院
    Shengjing Hospital
    状态
    招募中
    登记库
    NCT05263570

  69. 研究 Albumin-bound Paclitaxel Combined With Carboplatin Versus Epirubicin Combined With Docetaxel as Neoadjuvant Therapy for Triple-negative Breast Cancer: a Multicenter Randomized Controlled Phase IV Clinical Trial

    主要研究者
    Caigang Liu · Principal Investigator
    医院
    Shengjing Hospital
    状态
    招募中
    登记库
    NCT04136782

  70. 研究 The Association Between Plasma Metabolites and the Risk, Efficacy and Prognosis in Early Breast Cancer

    主要研究者
    Caigang Liu · director of oncology
    医院
    Shengjing Hospital
    状态
    招募中
    登记库
    NCT06698679

  71. 研究 A Phase I/II, Multi-site, Open-label, Two-part Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of BNT323 in Combination With BNT327 in Participants With Advanced Breast Cancer

    医院
    First Affiliated Hospital of Guangzhou Medical University
    状态
    招募中
    登记库
    NCT06827236

  72. 研究 A Phase II, Open-Label, Multicenter Clinical Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of TT-00420 (Tinengotinib) Tablets Combined With Fulvestrant Injection in Patients With Hormone Receptor-Positive (HR+) and Human Epidermal Growth Factor Receptor 2 (HER-2) Negative or Low-Expressing Recurrent or Metastatic Breast Cancer Who Have Failed Prior Treatment

    医院
    Guangdong Provincial People's Hospital
    状态
    招募中
    登记库
    NCT07498478

  73. 研究 Standard Chemotherapy Plus Moxifloxacin as First-line Treatment for Metastatic Triple-negative Breast Cancer : a Multicenter, Double-blind, Placebo-controlled, Phase 3 Trial

    主要研究者
    Zhong-yu Yuan · Clinical Professor
    医院
    Sun Yat-sen University Cancer Center
    状态
    招募中
    登记库
    NCT04722978

  74. 研究 A Novel Intraoperative Fluorescence-guided System for Evaluating Margins During Breast-conserving Surgery for Breast Cancer: A Prospective Randomized Controlled Trial

    主要研究者
    Kun Wang · Clinical Professor
    医院
    Guangdong Provincial People's Hospital
    状态
    招募中
    登记库
    NCT07352930

  75. 研究 A Phase II Single-Arm Clinical Study to Explore the Efficacy and Safety of Hyperbaric Oxygen in the Neoadjuvant Treatment of Breast Cancer Patients

    主要研究者
    Kun Wang · Professor
    医院
    Guangdong Provincial People's Hospital
    状态
    招募中
    登记库
    NCT06811870

  76. 研究 Clinical Cohort Study of 21-gene Assay in Predicting the Prognosis of Elder Luminal-A Breast Cancer Patients With Axillary Lymph Node Metastasis

    医院
    Qilu Hospital of Shandong University
    状态
    招募中
    登记库
    NCT06891651

  77. 研究 Prospective, One-arm, Phase II Clinical Study of Ivoximab Combined With TROP2 ADC in the Treatment of Brain Metastases in Triple-negative Breast Cancer

    主要研究者
    Jian Zhang,MD · Director of Phase I clinical Research ward
    医院
    Fudan University Shanghai Cancer Center
    状态
    招募中
    登记库
    NCT06793332

  78. 研究 Evaluating Safety and Efficacy of INtrathecal or Ommaya ReserVoir Administration of T-DXd in Patients With HER2-Expressing Breast Cancer With Active Leptomeningeal and/or Brain Metastases Based on Systemic Therapy: Phase I/II Study

    主要研究者
    Jian Zhang,MD · Director of Phase I Clinical Trial Department; Professor, Chief physician of oncology department
    医院
    Fudan University Shanghai Cancer Center
    状态
    招募中
    登记库
    NCT07134153

  79. 研究 A Prospective, Randomized, Open-label Phase III Clinical Study of the Efficacy and Safety of Fluzoparib Combined With Adjuvant Endocrine Therapy Versus Adjuvant Endocrine Therapy for HR+/HER2- SNF3-subtype Early Breast Cancer (BCTOP-L-A01)

    主要研究者
    Zhimin Shao · Chief Physician
    医院
    Peking University Cancer Hospital
    状态
    招募中
    登记库
    NCT05891093

  80. 研究 Cohort Study of Adjuvant Chemotherapy Combined With Targeted Therapy for Intermediate Risk HER2 Positive and Lymph Node Negative Early Breast Cancer

    主要研究者
    Shu Wang · director of breast center
    医院
    Peking University People's Hospital
    状态
    招募中
    登记库
    NCT06711068

  81. 研究 A Phase III, Multicenter, Randomized, Open-Label Parallel-Controlled Study of Trastuzumab Rezetecan (SHR-A1811) in Combination With Adebrelimab (SHR-1316) Versus Investigator's Choice of Therapy in Subjects With Primary Triple Negative Breast Cancer Who Have Residual Invasive Disease Following Neoadjuvant Therapy

    医院
    Cancer Hospital of Chinese Academy of Medical Sciences
    状态
    招募中
    登记库
    NCT07679360

  82. 研究 IZABRIGHT-Breast01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-986507) Versus Treatment of Physician's Choice in Patients With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer (TNBC) or ER-low, HER2-negative BC Who Are Ineligible for Anti-PD1/PD-L1 Treatment

    医院
    Anhui Provincial Hospital
    状态
    招募中
    登记库
    NCT06926868

  83. 研究 A Randomized Controlled Phase II/III Clinical Study of BL-M07D1 With or Without Pertuzumab Versus Docetaxel + Carboplatin + Trastuzumab + Pertuzumab in Neoadjuvant Therapy for HER2-Positive Breast Cancer

    医院
    First Affiliated Hospital of Guangzhou Medical University
    状态
    招募中
    登记库
    NCT06891833

  84. 研究 A Randomized, Open-label, Multicenter, Parallel-controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of TQB2102 for Injection Versus TCbHP in Neoadjuvant Treatment of Breast Cancer With Positive HER2 Expression

    医院
    First Affiliated Hospital of Guangzhou Medical University
    状态
    招募中
    登记库
    NCT07043725

  85. 研究 The Safety and Efficacy of IMPT or IMRT for Breast Cancer: A Prospective Observational Study

    主要研究者
    JIAYI CHEN · Chair of Radiation Oncology Department
    医院
    Ruijin Hospital
    状态
    招募中
    登记库
    NCT06826885

  86. 研究 Prospective Randomized Controlled Study on Precision Irradiation of Regional Lymph Node for Clinical High-risk pN0 Breast Cancer

    主要研究者
    JIAYI CHEN · Prof
    医院
    Ruijin Hospital
    状态
    招募中
    登记库
    NCT05976412

  87. 研究 Early Prediction and Warning for Cardiotoxicity Due to Anthracycline-Based Breast Cancer Chemotherapy: a Prospective, Multicenter, Clinical Trial

    主要研究者
    Chunyan Ma · Chief of Cardiovascular Ultrasound
    医院
    First Hospital of China Medical University
    状态
    招募中
    登记库
    NCT06282796

  88. 研究 A Phase 2 Trial of SHR2554 Combined With Endocrine Therapy in Advanced Breast Cancer

    主要研究者
    Min Yan, MD · Chief physician
    医院
    Henan Cancer Hospital
    状态
    尚未招募
    登记库
    NCT07125950

  89. 研究 Sensitivity and Specificity of Ultrasound-Guided Core Needle Biopsy in Evaluating Axillary Lymph Node Metastasis in Breast Cancer

    主要研究者
    Dezhi Zhang · Principal Investigator (PI)
    医院
    The First Hospital of Jilin University
    状态
    尚未招募
    登记库
    NCT07573657

  90. 研究 A Multicenter, Randomized, Controlled, Open Label Clinical Study on the Treatment of Recurrent or Metastatic Triple Negative Breast Cancer With Cadonilimab Combined With Eribulin Versus Eribulin Alone

    主要研究者
    Caigang Liu · Postdoctoral, Chief Physician
    医院
    Shengjing Hospital
    状态
    尚未招募
    登记库
    NCT06202313

  91. 研究 An Open-label, Randomized, Multi-center, Multi-cohort Clinical Study of JS004 and Toripalimab Combined With Chemotherapy vs Toripalimab Combined With Chemotherapy vs Chemotherapy Alone as Neoadjuvant Therapy for Stage II-III Triple-negative Breast Cancer (TNBC).

    主要研究者
    Caigang Liu · Shengjing Hospital
    医院
    Shengjing Hospital
    状态
    尚未招募
    登记库
    NCT07101614

  92. 研究 A Phase II Single-Arm Clinical Study to Explore the Efficacy and Safety of Hyperbaric Oxygen in the Neoadjuvant Treatment of Triple-Negative and HER2+ Breast Cancer Patients

    主要研究者
    Kun Wang · PhD
    医院
    Guangdong Provincial People's Hospital
    状态
    尚未招募
    登记库
    NCT06825975

  93. 研究 A Phase 2, Single Arm Study Investigating the Use of Chidamide and PD-1 Antibody Combination With Anlotinib in HER2-low, Unresectable and/or Metastatic Breast Cancer

    主要研究者
    Kun Wang · Professor
    医院
    Guangdong Provincial People's Hospital
    状态
    尚未招募
    登记库
    NCT06547476

  94. 研究 Neratinib Combined With Fulvestrant and Eribulin in the Treatment ofHR+/HER2+ Advanced Breast Cancer After Trastuzumab Deruxtecan Resistance:A Single-Arm, Multicenter, Exploratory Clinical Study

    状态
    尚未招募
    登记库
    NCT07333937

  95. 研究 Tolerability of Dalpiciclib Versus Abemaciclib/Ribociclib in Combination With Standard Endocrine Therapy for HR-Positive/HER2-Negative Early Breast Cancer: A Prospective, Multicenter, Randomized Controlled Trial

    主要研究者
    Zhenzhen Liu · Professor
    医院
    Henan Cancer Hospital
    状态
    尚未招募
    登记库
    NCT07706933

  96. 研究 A Multicenter, Prospective, Randomized Two-arm Controlled Trial Comparing the Impact of Robotic Versus Endoscopic Surgery on Breast Nerve Function Following Nipple-sparing Mastectomy for Breast Cancer

    主要研究者
    haiyanli · Chief Physician, Department of Breast Surgery
    医院
    Guangzhou Women and Children's Medical Center
    状态
    尚未招募
    登记库
    NCT07850154

  97. 研究 Randomized Controlled Clinical Study of Efficacy and Safety of Initumab Combined with Pyrrotinib and Chemotherapeutic Agents in Neoadjuvant Therapy for HER2-positive Breast Cancer with Different Treatment Cycles

    医院
    The First Hospital of Jilin University
    状态
    尚未招募
    登记库
    NCT06868017

  98. 研究 Efficacy and Safety of SHR-A1811 Versus Pyrotinib Plus Capecitabine in Patients With Trastuzumab Primary-Resistant HER2-Positive Advanced Breast Cancer：A Prospective, Multicenter, Open-Label, Randomized, Controlled Study

    主要研究者
    Hanfang Jiang, MD · Professor
    医院
    Peking University Cancer Hospital
    状态
    尚未招募
    登记库
    NCT07417241

  99. 研究 A Clinical Model Based on Dynamic Changes in Anti-Müllerian Hormone to Predict Ovarian Reserve in Perimenopausal Breast Cancer Patients

    主要研究者
    Jianyi Li · Chief Physician
    医院
    Shengjing Hospital
    状态
    尚未招募
    登记库
    NCT07497191

  100. 研究 Trastuzumab Combined With Pertuzumab and Sequential Use of Pyrotinib vs. Trastuzumab Combined With Pertuzumab for Adjuvant Treatment of Breast Cancer After Neoadjuvant Therapy

    主要研究者
    Caigang Liu · Director
    医院
    Shengjing Hospital
    状态
    尚未招募
    登记库
    NCT04973319

  101. 研究 Fasting-Mimicking Diet as an Adjunct to Neoadjuvant Chemotherapy for Hormone-Receptor-Positive Breast Cancer

    主要研究者
    Kun Wang · Professor
    医院
    Guangdong Provincial People's Hospital
    状态
    尚未招募
    登记库
    NCT07077018

  102. 研究 A Prospective Study to Evaluate the Clinical Significance of Medical Humanities-based Patient Education Strategy for Breast Cancer Patients During Perioperative Hospitalization Stage

    主要研究者
    Jiong Wu · Principal Investigator
    医院
    Fudan University Shanghai Cancer Center
    状态
    尚未招募
    登记库
    NCT06965556

  103. 研究 针刺治疗激素受体阳性乳腺癌患者潮热的随机对照试验研究，A Randomized Controlled Trial of Acupuncture for the Management of Hot Flashes in Patients With Hormone Receptor-Positive Breast Cancer

    主要研究者
    Shu Wang · director of breast center
    医院
    Peking University People's Hospital
    状态
    尚未招募
    登记库
    NCT07294339

  104. 研究 A Multicenter, Single-Arm, Open-Label Study of Extended Sentinel Lymph Node Biopsy Using Methylene Blue as a Single Tracer After Neoadjuvant Therapy in Patients With Axillary Node-Positive Breast Cancer

    状态
    尚未招募
    登记库
    NCT07532096

  105. 研究 SHR-A1811 and THPy in First or Second Line for HER2 Positive Advanced Breast Cancer Brain Metastases

    医院
    Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
    状态
    尚未招募
    登记库
    NCT06975475

  106. 研究 Effect of Continuous Intraoperative Esketamine Infusion on Perioperative Negative Emotions in Breast Cancer Surgery Patients With Mild-to-Severe Depression: A Randomized Controlled Trial

    主要研究者
    Weidong Mi · Director (Cheif expert of National key research and development program of China 2018YFC2001900)
    医院
    Chinese PLA General Hospital
    状态
    尚未招募
    登记库
    NCT07374198

  107. 研究 Effects of Acupuncture for Anxiety and/or Depression Among Patients With Breast Cancer

    主要研究者
    Yuanjie Sun · Attending physician
    医院
    Guang'anmen Hospital of China Academy of Chinese Medical Sciences
    状态
    尚未招募
    登记库
    NCT07183813

  108. 研究 Correlation Between COVID-19 and Radiation Pneumonitis in Breast Cancer: A Historical Cohort Study

    医院
    Zhejiang Hospital
    状态
    尚未招募
    登记库
    NCT07188116

  109. 研究 A Prospective Clinical Study Evaluating Bemotuzumab Combined With Chemotherapy to Improve the Efficacy of Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer (TNBC)

    主要研究者
    Xuli Meng · Chief physician
    医院
    Zhejiang Provincial People's Hospital
    状态
    尚未招募
    登记库
    NCT06975644

  110. 研究 A Phase Ib, Open-label, Modular Trial to Evaluate Sacituzumab Govitecan in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Metastatic Breast Cancer Progressed on CDK4/6 Inhibitors

    医院
    Hunan Cancer Hospital
    状态
    尚未招募
    登记库
    NCT07163481

  111. 研究 The Efficacy and Safety of Lenvatinib Combined With Sindilimab and Nab-paclitaxel in the First-line Treatment for Recurrent and Metastatic Triple Negative Breast Cancer: a Phase Ib/IIa Clinical Trial.

    主要研究者
    Wang Xiaojia · chief physician
    医院
    Zhejiang Cancer Hospital
    状态
    尚未招募
    登记库
    NCT06140576

  112. 研究 A Prospective and Multicenter Clinical Study to Identify the Molecular Characterization and Subtypes in Patients With HER2-positive Breast Cancer Receiving Neoadjuvant Trastuzumab and Pertuzumab.

    主要研究者
    Jinming Yu · PhD, MD
    医院
    Shandong Cancer Hospital
    状态
    尚未招募
    登记库
    NCT07187752

  113. 研究 Efficacy and Safety of Pedicled Lateral Chest Wall Lymph-Adipofascial Flap Axillary Reconstruction for the Prevention of Breast Cancer-Related Arm Lymphedema: A Prospective, Single-Arm, Phase II Clinical Study

    医院
    Sun Yat-sen Memorial Hospital, Sun Yat-sen University
    状态
    尚未招募
    登记库
    NCT07415200

  114. 研究 A Multicenter, Prospective Phase II Single-arm Study Evaluating the Efficacy and Safety of Neoadjuvant Treatment with T-DXd in Combination with an Immune Checkpoint Inhibitor in HR-positive HER2 Low-expressing Chinese Patients with Early-stage Breast Cancer

    主要研究者
    Huijin Wang · Director of Thyroid and Breast Disease Center
    医院
    Guangzhou Women and Children's Medical Center
    状态
    尚未招募
    登记库
    NCT06733233

  115. 研究 Phase I/II Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of TQB3126 in Subjects With Breast Cancer

    医院
    Sun Yat-sen Memorial Hospital, Sun Yat-sen University
    状态
    尚未招募
    登记库
    NCT07697443

  116. 研究 A Two-cohort Study of SHR-A1811 in the Treatment of HER2-positive Breast Cancer With Brain Metastases, With or Without Leptomeningeal Metastases.

    医院
    Peking University Cancer Hospital
    状态
    尚未招募
    登记库
    NCT07177950

  117. 研究 A Prospective, Double-Arm Study on the Optimization of Dynamic Neoadjuvant Therapy Strategies for HER2-Positive Breast Cancer Based on HER2-PET/CT Molecular Imaging

    主要研究者
    xuliang · professor
    医院
    Peking University Cancer Hospital
    状态
    尚未招募
    登记库
    NCT07527806

  118. 研究 Prospective Evaluation of Sentinel Lymph Node Biopsy Combined With Wire Localized Lymph Node Biopsy for Omitting Axillary Lymph Node Dissection in Breast Cancer Patients With 1-2 Sonographically Abnormal Lymph Nodes: A Diagnostic Study

    医院
    Peking University Cancer Hospital
    状态
    尚未招募
    登记库
    NCT07791771

  119. 研究 Study on the Safety and Efficacy of Autogenous Tumor Infiltrates Lymphocytes (HS-IT101) for the Treatment of Advanced Breast Cancer

    医院
    The Affiliated Hospital of Qingdao University
    状态
    尚未招募
    登记库
    NCT05505812

  120. 研究 A Single-Center Retrospective Study to Develop a Nomogram for Predicting Recurrence in HR+/HER2- Early Breast Cancer Using Real-World Data

    主要研究者
    Jianyi Li · Principal Investigator
    医院
    Shengjing Hospital
    状态
    尚未招募
    登记库
    NCT07484763

  121. 研究 An Exploration of Hyperbaric Oxygen in the Treatment of Flap Ischaemic Necrosis After Breast Cancer Surgery

    主要研究者
    Kun Wang · Professor
    医院
    Guangdong Provincial People's Hospital
    状态
    尚未招募
    登记库
    NCT06811857

  122. 研究 A Multicenter, Randomized, Open-Label, Controlled Phase II Clinical Study of Paclitaxel Polymeric Micelles Combined With Trastuzumab and Pertuzumab (HP) and Adebelimab Versus Taxane Combined With HP as First-Line Treatment for Advanced HER2-Positive Breast Cancer

    主要研究者
    Jian Zhang,MD · Director of Phase I Unit，Chief physician of oncology department
    医院
    Fudan University Shanghai Cancer Center
    状态
    尚未招募
    登记库
    NCT07581795

  123. 研究 A Multicenter, Prospective, Randomized Phase II Trial Evaluating Trastuzumab, Pertuzumab, Docetaxel Combined With QL1706 Versus Combined With Carboplatin as Neoadjuvant Therapy for Early or Locally Advanced HER2+ Breast Cancer

    医院
    Guangdong Provincial People's Hospital
    状态
    尚未招募
    登记库
    NCT07246317

  124. 研究 Clinical Study of SHR-A1811 With or Without Letrozole in Neoadjuvant Therapy for Early-Stage HR-Positive, HER2-Low Breast Cancer

    主要研究者
    Yingying Xu · Professor
    医院
    First Hospital of China Medical University
    状态
    尚未招募
    登记库
    NCT07305246

  125. 研究 TREND-02 - a Phase II Exploratory De-escalation Trial of Neoadjuvant Sacituzumab Govitecan Plus Tislelizumab (SG/I) in Early Triple-negative Breast Cancer

    主要研究者
    Yingying Xu · Professor
    医院
    First Hospital of China Medical University
    状态
    尚未招募
    登记库
    NCT07271992

  126. 研究 Effect of Intraoperative Transcutaneous Auricular Vagus Nerve Stimulation on Perioperative Negative Emotions in Patients Undergoing Breast Cancer Surgery: A Multicenter, Randomized, Double-Blind, Sham-Controlled Trial

    主要研究者
    Weidong Mi · Director (Cheif expert of National key research and development program of China 2018YFC2001900)
    医院
    Beijing Tiantan Hospital, Capital Medical University
    状态
    尚未招募
    登记库
    NCT07458646

本页仅分享公开登记的研究信息，不推荐也不鼓励参加任何研究。参加完全自愿，且未经批准治疗的风险尚不明确；请直接联系医院了解入组条件与知情同意细节。

先进疗法：哪些已获批、哪些在试验中

拥有国家临床重点专科记录的医院

显示医院记录 5 家拥有重点专科记录的医院

每一行都是在某疾病所归属专科中拥有国家临床重点专科记录的医院。这是对已发布名单的记录，既不构成推荐，也不是排名。

医院 城市 专科（按原样） 证据 来源
四川大学华西医院West China Hospital, Sichuan University
三级 · 最高档
 成都市 Chengdu 乳腺恶性肿瘤多学科精准诊疗平台（普通外科） A 级 https://wcums.scu.edu.cn/kxyan_jiu/gjlczdzk.htm
山东大学齐鲁医院Qilu Hospital of Shandong University
三级 · 最高档
 济南市 Jinan 乳腺外科 A 级 https://file.byfy.cn/Resource/File/Upload/file/20251204/20251204085449_9136.pdf
山东省肿瘤医院Shandong Cancer Hospital 济南市 Jinan 乳腺外科 A 级 https://file.byfy.cn/Resource/File/Upload/file/20251204/20251204085449_9136.pdf
湖北省肿瘤医院Hubei Cancer Hospital 武汉市 Wuhan 乳腺中心 B 级 https://www.hbch.com.cn/category/1-11.html
湖南省肿瘤医院Hunan Cancer Hospital
三级 · 最高档
 长沙市 Changsha 乳腺癌诊疗中心（国家级建设项目） B 级 https://hnca.org.cn/wap/zdks/

5 家拥有匹配的国家临床重点专科记录的医院。

以中文写出的数值按来源原样引用。

患者报告的情况

仅为汇总数据：一项全国性结果，附其来源与所指年份。这不是患者证言，也不是关于某一个人的陈述。

  • 据 National Health Commission - 2023 national tertiary public hospital performance monitoring circular (国卫医政函〔2025〕55 号)（2023）报道：National inpatient satisfaction / outpatient satisfaction — 95.42 / 93.95 score, 0-100。

    National aggregate across the 2,168 tertiary public hospitals that took part in the national performance monitoring (all conditions combined; not disease-specific, not hospital-specific).

    来源：National Health Commission - 2023 national tertiary public hospital performance monitoring circular (国卫医政函〔2025〕55 号) — https://www.gov.cn/zhengce/zhengceku/202503/content_7016208.htm — 2023 — A 级

全部疗法与获取主题

关于该疾病的问题

我们不能提供医疗建议，但可以回答关于本页以及在中国安排就医的问题。

咨询这个病种

ICD 编码

显示编码表 10 个 ICD 编码
版本 编码 该版本中的名称
ICD-10-WHO C50 Malignant neoplasm of breast
ICD-10-WHO C50.0 Nipple and areola
ICD-10-WHO C50.1 Central portion of breast
ICD-10-WHO C50.2 Upper-inner quadrant of breast
ICD-10-WHO C50.3 Lower-inner quadrant of breast
ICD-10-WHO C50.4 Upper-outer quadrant of breast
ICD-10-WHO C50.5 Lower-outer quadrant of breast
ICD-10-WHO C50.6 Axillary tail of breast
ICD-10-WHO C50.8 Overlapping lesion of breast
ICD-10-WHO C50.9 Breast, unspecified

各行为该疾病的 WHO ICD-10 条目，按原样引用。

来源与证据

来源 URL
https://wjw.fujian.gov.cn/xxgk/fgwj/zxwj/201904/P020190412506737868905.xlsx
来源协议
https
来源类型
省级卫生健康委员会
证据等级
A ——由卫生健康委员会、国家级研究机构或大学所述
获取日期
2026-09-24